Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Disease/ Diagnostics

show results
Refine your search

Search term:

Results 1 - 10 of 27 > >>
EC Number Disease PubMed ID Title of Publication Category Confidence Level
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Aneurysm 27216312 Validation of the Simbionix PROcedure Rehearsal Studio sizing module: A comparison of software for endovascular aneurysm repair sizing and planning. therapeutic application
unassigned
1
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Carcinogenesis 27612429 EPRS is a critical regulator of cell proliferation and estrogen signaling in ER+ breast cancer. causal interaction
unassigned
3
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Coccidiosis 28867614 Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. therapeutic application
unassigned
4
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Coinfection 30521835 A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses. therapeutic application
unassigned
1
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15COVID-19 33791697 The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. causal interaction
ongoing research
therapeutic application
unassigned
1
2
4
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Cryptosporidiosis 28867614 Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and Coccidiosis. therapeutic application
unassigned
4
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Dengue 30521835 A potent prolyl tRNA synthetase inhibitor antagonizes Chikungunya and Dengue viruses. therapeutic application
unassigned
1
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Diffuse Cerebral Sclerosis of Schilder 25629079 Whole exome sequencing reveals mutations in NARS2 and PARS2, encoding the mitochondrial asparaginyl-tRNA synthetase and prolyl-tRNA synthetase, in patients with Alpers syndrome. causal interaction
unassigned
1
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Diffuse Cerebral Sclerosis of Schilder 29915213 The genotypic and phenotypic spectrum of PARS2-related infantile-onset encephalopathy. causal interaction
unassigned
1
0
Show all pathways known for 6.1.1.15Display the word mapDisplay the reaction diagram Show all sequences 6.1.1.15Gastroenteritis 25759500 Identification of a gamma interferon-activated inhibitor of translation-like RNA motif at the 3' end of the transmissible gastroenteritis coronavirus genome modulating innate immune response. unassigned 0
Results 1 - 10 of 27 > >>